Treatment Of Pigs With Pcv2 Antigen

Patent No. EP2094872 (titled "Treatment Of Pigs With Pcv2 Antigen") was filed by Boehringer Ingelheim on Dec 14, 2007. The application was issued on Feb 19, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
INTERVETNov 22, 2017INTERVET

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2094872

BOEHRINGER INGELHEIM
Application Number
EP07869309A
Filing Date
Dec 14, 2007
Status
Patent Maintained As Amended
Jan 17, 2020
Publication Date
Feb 19, 2020